Category: MARKET INSIGHTS
Skin Cancers: The Sunny Challenge of Future (Potential Drugs and Treatments in Development)
KEY POINTS Ozone depletion, greenhouse gas-induced global warming, rising earth temperature is interacting to put a severe effect on human ...
Billion Dollars Healthcare Startups (2018)
KEY POINTS A unicorn is a startup company with a current valuation of US$1 billion or more. Medgenera DATALABS has ...
Telemedicine a Blooming Area, Global Investments to Reach ~1 Billion in 2018: Medgenera Report
KEY POINTS About $725.9 million has been invested in telemedicine segment in 2017 by the global investors: Report Telemedicine is ...
Pharma Giants Gradually Embracing Digital Healthcare Technologies
Big pharma players including Novartis, Roche, Pfizer, Sanofi are embracing digital technologies to deliver better to the patients. FDA’S 2018 Strategic Policy Roadmap indicates increasing number of digital health clearances in coming times with revised regulatory processes.
Is Novartis Betting High to Give First FDA-Approved Gene Therapy for Spinal Muscular Atrophy?
Novartis bets high by acquiring the non-earning US-based gene therapy firm AveXis for $8.7 billion. But, AveXis' novel gene therapy- AVXS-101 could be a “game-changing” treatment for SMA patients and could turn out to be a potential blockbuster for Novartis, if approved.
‘Breath Biopsy’ Stands in Competition with ‘Liquid Biopsy’ as Next-Gen Cancer Diagnostics
KEY POINTS Breath Biopsy analyzes individual’s breath for biomarkers, signifying the metabolic conditions and cancer diagnosis of the person. GlaxoSmithKline ...
Sanofi’s Cholesterol-Lowering, Praluent® Wins Big Battle; will Become Cost-Effective
KEY POINTS Praluent is a cholesterol-lowering monoclonal antibody, significantly reduces the combined risk of cardiovascular problems and related deaths in ...
9 Most Valuable Drugs Under Development (2018)
KEY POINTS The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These ...
Bristol-Myers Squibb Rises High with the Star Performer ‘Opdivo’
KEY POINTS Bristol-Myers Squibb’s (BMS) has shown stellar growth in its revenue (by 7 percent) in 2017. BMS’s Immuno-oncology drug, ...
mRNA Therapy Startup Moderna Deck up its Value to $7 Billion
KEY POINTS With the latest equity financing of US $500M, Moderna is now the most valued healthcare unicorn startup in ...